CD123 Redirected Autologous T Cells for AML

Clinical trial NCT02623582 · TERMINATED

Trial details

NCT number

NCT02623582

Sponsor

University of Pennsylvania

Status

TERMINATED

Phase

Early Phase 1

Study type

INTERVENTIONAL

Start date

2015-12-01

Primary completion

2016-08-26

Enrollment

7

View on ClinicalTrials.gov